All Q4 FY25 results →
R

RSWM Ltd

Q4 FY25Textiles & Apparels

RSWM Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management guided on revenue, margins and order book.

Price₹205
Market cap₹1.1K Cr
P/E14.7
Updated23 Aug 2026
Read4 min read

The short version

RSWM is optimistic about future growth driven by improved order visibility and balanced product mix (Page 5-6). RSWM reported a 44.8% YoY increase in Q4 FY25 EBITDA and improved EBITDA margin to 6.2% from 4.6% last year, indicating an upward earnings trend.

From RSWM Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • RSWM is optimistic about future growth driven by improved order visibility and balanced product mix (Page 5-6).
  • Focus on consolidating market position with quality and value-added products, targeting new customers and markets especially in Middle East, Europe, and America (Page 10).
  • Expectation of better performance in coming quarters evidenced by improved EBITDA margins and utilization levels (Page 16).
  • Growth supported by favorable trade agreements like the India-UK Free Trade Agreement, with potential to increase export share in the UK apparel market from 6% to 15-20% (Page 5).
  • Concentration on sustainability, innovative product development, and operational efficiencies to drive sales (Page 10).

2 more points from RSWM Ltd's call on revenue

Pro opens every point from 15K+ earnings calls

Profitability & Margins

See what RSWM Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • For the current financial year (FY26), RSWM Limited plans only normal maintenance capital expenditure and balancing equipment to enhance utilization; no major modernization or large CAPEX is proposed, especially for the Ginni Filament Chhata unit.
  • The company continues to invest in power efficiency improvements, focusing on reducing power consumption and increasing green power usage (solar and wind).
  • No new investments are planned for product development at this time, although RSWM invests in product centers focusing on innovation and co-creating with customers for value-added products.

2 more points from RSWM Ltd's call on capex

Pro opens every point from 15K+ earnings calls

Top-ranked in Textiles & Apparels

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
2Purple United
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 2
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what RSWM Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • The transcript does not provide specific figures or details regarding the current or expected order book or pending orders for RSWM Limited.
  • However, it mentions improved utilization levels across verticals with yarn utilization in high 90%+, denim post-90%, and knitting in mid-80%, indicating a healthy production demand.
  • The company cites good demand in markets like Bangladesh and highlights efforts to acquire new customers and improve efficiency.
  • Q1 of the new financial year (FY26) is anticipated to perform at least as well as Q4 FY25 or slightly better.

2 more points from RSWM Ltd's call on order book

Pro opens every point from 15K+ earnings calls

RSWM Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.1K Cr, net profit ₹34 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Textiles & Apparels this season

  • Lux Industries (Q4 FY25)

    818 crores, a 16% YoY growth (Page 34) . Key concall takeaways from Lux Industries Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • K P R Mill Ltd (Q4 FY25)

    Q4 FY25: ₹1,768.98 crores . Key concall takeaways from K P R Mill Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Trident (Q4 FY25)

    Q4 FY25 Standalone Total Income: INR 18,777 million, up 10.48% YoY from INR 16,996 million in Q4 FY24 (Page 26). Key concall takeaways from Trident Ltd's Q4…

  • Sangam (India) Ltd (Q4 FY25)

    Q4 FY25 Revenue: ₹746 crore, up 6% YoY (Page 11) . Key concall takeaways from Sangam (India) Ltd's Q4 FY25 earnings call — and how it ranks against sector…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

RSWM Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were RSWM Ltd Q4 FY25 results?

RSWM is optimistic about future growth driven by improved order visibility and balanced product mix (Page 5-6). RSWM reported a 44.8% YoY increase in Q4 FY25 EBITDA and improved EBITDA margin to 6.2% from 4.6% last year, indicating an upward earnings trend.

What is RSWM Ltd share price analysis?

RSWM Ltd currently shows a neutral. The stock trades at a P/E of 14.7 with a market cap of ₹1,058 Cr. Investors should review the full earnings analysis for detailed insights.

Is RSWM Ltd planning capital expenditure?

For the current financial year (FY26), RSWM Limited plans only normal maintenance capital expenditure and balancing equipment to enhance utilization; no major modernization or large CAPEX is proposed, especially for the Ginni Filament Chhata unit.

Keep RSWM Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.